Pfizer begins study for COVID-19 antiviral drug



Pfizer logo is reflected in a drop on a syringe needle in this illustration photo taken March 16, 2021. REUTERS/Dado Ruvic/IllustrationSept 27 (Reuters) – Pfizer Inc (PFE.N) said on Monday it has started a mid-to-late-stage study testing its investigational oral antiviral drug, to be co-administered with HIV drug ritonavir, for the prevention of COVID-19 infection.Reporting by Manojna Maddipatla in Bengaluru; Editing by Krishna Chandra EluriOur Standards: The Thomson Reuters Trust Principles.



Source link

Leave a Comment

%d bloggers like this: